entity

phenytoin

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about phenytoin: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

7Connections
0Hypotheses
0Analyses
2Outgoing
0Incoming

Wiki Pages (20)

Knowledge base pages for this entity

Rapamycin ALS Trial - mTOR Inhibition for Amyotrophic Lateral Sclerosis

clinical · 4511 words

vitamin-d-therapy-neurodegeneration

therapeutic · 4119 words

rapamycin-tauopathy

therapeutic · 3805 words

Hypera Pharma

company · 3524 words

bbb-transport-mechanisms

mechanism · 3506 words

Outgoing (7)

TargetRelationTypeStr
GFAPinteracts_withprotein0.90
GFAP Aggregationinhibitsprocess0.85

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found